Value Line, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Value Line, Inc. on January 16, 2026. The report addresses corporate governance changes, specifically the departure of a director due to death and the subsequent appointment of a new director to the Board of Directors and the Audit Committee.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Director Departure: Mr. Alfred R. Fiore, a director since 2010, passed away on December 6, 2025.
- Director Appointment: On January 16, 2026, Dr. Alexander J. Swistel was appointed as a director and member of the Audit Committee.
- Compensation: Dr. Swistel will receive an annual director's fee of $40,000, consistent with other Audit Committee members.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, risks, contingencies, or unusual items. The document confirms no undisclosed arrangements or family relationships exist regarding the new director's appointment.
Key Facts for Investor Verification
- Verify the effective date of Dr. Swistel's appointment (January 16, 2026).
- Confirm the annual compensation structure for Audit Committee members ($40,000).
- Note the vacancy created by the death of long-serving director Alfred R. Fiore.
- Review Dr. Swistel's background as a retired Associate Professor at Weill Cornell Medical College.